Comparison of continuous infusion and bolus administration of ifosfamide in children
- 1 January 1995
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 785-790
- https://doi.org/10.1016/0959-8049(95)00090-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamideBiochemical Pharmacology, 1994
- Ifosfamide, mesna, and nephrotoxicity in children.Journal of Clinical Oncology, 1993
- Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehydeBiochemical Pharmacology, 1992
- Ifosfamide in pediatric oncologyAnti-Cancer Drugs, 1991
- Dosing and side-effects of ifosfamide plus mesnaZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.Journal of Clinical Oncology, 1989
- Metabolism of oxazaphosphorinesPharmacology & Therapeutics, 1988
- DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITYThe Lancet, 1986